van de Velde CJH - Search Results

1

The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival.

Houtsma D, de Groot S, Baak-Pablo R, Kranenbarg EM, Seynaeve CM, van de Velde CJH, Böhringer S, Kroep JR, Guchelaar H-, Gelderblom H. Houtsma D, et al. Among authors: van de velde cjh, de groot s. Sci Rep. 2021 Feb 5;11(1):3249. doi: 10.1038/s41598-021-82002-z. Sci Rep. 2021. PMID: 33547330 Free PMC article. Clinical Trial.

2

Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients.

Beerman H, Kluin PM, Hermans J, van de Velde CJ, Cornelisse CJ. Beerman H, et al. Int J Cancer. 1990 Jan 15;45(1):34-9. doi: 10.1002/ijc.2910450108. Int J Cancer. 1990. PMID: 2298504

3

Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.

Clahsen PC, van de Velde CJ, Julien JP, Floiras JL, Delozier T, Mignolet FY, Sahmoud TM. Clahsen PC, et al. J Clin Oncol. 1996 Mar;14(3):745-53. doi: 10.1200/JCO.1996.14.3.745. J Clin Oncol. 1996. PMID: 8622020 Clinical Trial.

4

Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis.

van der Hage JA, Putter H, Bonnema J, Bartelink H, Therasse P, van de Velde CJ; EORTC Breast Cancer Group. van der Hage JA, et al. Eur J Cancer. 2003 Oct;39(15):2192-9. doi: 10.1016/s0959-8049(03)00572-0. Eur J Cancer. 2003. PMID: 14522378

5

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

Kubben FJ, Sier CF, Meijer MJ, van den Berg M, van der Reijden JJ, Griffioen G, van de Velde CJ, Lamers CB, Verspaget HW. Kubben FJ, et al. Br J Cancer. 2006 Sep 18;95(6):744-51. doi: 10.1038/sj.bjc.6603307. Epub 2006 Aug 29. Br J Cancer. 2006. PMID: 16940985 Free PMC article.

6

[Optimal adjuvant hormone therapy in postmenopausal women with hormone-sensitive mammary carcinoma: tamoxifen and the aromatase inhibitors anastrozole, exemestane and letrozole].

van Nes JG, Seynaeve C, van de Velde CJ, Nortier JW. van Nes JG, et al. Ned Tijdschr Geneeskd. 2006 Dec 30;150(52):2863-9. Ned Tijdschr Geneeskd. 2006. PMID: 17319217 Review. Dutch.

7

A multivariate analysis of limiting factors for stoma reversal in patients with rectal cancer entered into the total mesorectal excision (TME) trial: a retrospective study.

den Dulk M, Smit M, Peeters KC, Kranenbarg EM, Rutten HJ, Wiggers T, Putter H, van de Velde CJ; Dutch Colorectal Cancer Group. den Dulk M, et al. Lancet Oncol. 2007 Apr;8(4):297-303. doi: 10.1016/S1470-2045(07)70047-5. Lancet Oncol. 2007. PMID: 17395102

8

Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: a clinical and pharmacologic evaluation.

van Iersel LB, Verlaan MR, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Sparidans RW, Gelderblom H, Kuppen PJ, Tollenaar RA, van de Velde CJ. van Iersel LB, et al. Eur J Surg Oncol. 2007 Sep;33(7):874-81. doi: 10.1016/j.ejso.2007.02.022. Epub 2007 Apr 2. Eur J Surg Oncol. 2007. PMID: 17400422

9

Preoperative chemotherapy for women with operable breast cancer.

Mieog JS, van der Hage JA, van de Velde CJ. Mieog JS, et al. Cochrane Database Syst Rev. 2007 Apr 18;2007(2):CD005002. doi: 10.1002/14651858.CD005002.pub2. Cochrane Database Syst Rev. 2007. PMID: 17443564 Free PMC article. Review.

10

Neoadjuvant chemotherapy for operable breast cancer.

Mieog JS, van der Hage JA, van de Velde CJ. Mieog JS, et al. Br J Surg. 2007 Oct;94(10):1189-200. doi: 10.1002/bjs.5894. Br J Surg. 2007. PMID: 17701939 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

864 results

Search Page